TherapeuticsMD, Inc. Stock Price

NasdaqGS:TXMD Community·US$19.7m Market Cap

0 Narratives written by author
0 Comments on narratives written by author
2 Fair Values set on narratives written by author

Create a narrative

TXMD Share Price Performance

US$1.70

0.61 (55.96%)

US$1.70

0.61 (55.96%)

US$1.70

Fri, 26 Dec 25

Share Pricen/a

TXMD Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Trending Discussion

Snowflake Analysis

Flawless balance sheet with slight risk.

4 Risks

2 Rewards

View Full Analysis

TherapeuticsMD, Inc. Key Details

Last Reported Earnings

Sep 30, 2025

Next Reporting Earnings

n/a

: 0.0063
: 100.00%
: 2.61%
: 0%

View Full Analysis

About TXMD

Founded: 2008
Employees: 1
CEO: Marlan Walker
WebsiteView website: www.therapeuticsmd.com

TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.